These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 34919042

  • 1. Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren's syndrome.
    Loureiro-Amigo J, Franco-Jarava C, Perurena-Prieto J, Palacio C, Martínez-Valle F, Soláns-Laqué R.
    Clin Exp Rheumatol; 2021; 39 Suppl 133(6):131-139. PubMed ID: 34919042
    [Abstract] [Full Text] [Related]

  • 2. CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.
    Mandal SK, Sandhya P, Kabeerdoss J, Ramya J, Mahasampath G, Danda D.
    Rheumatol Int; 2018 May; 38(5):831-836. PubMed ID: 29541901
    [Abstract] [Full Text] [Related]

  • 3. Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.
    Nishikawa A, Suzuki K, Kassai Y, Gotou Y, Takiguchi M, Miyazaki T, Yoshimoto K, Yasuoka H, Yamaoka K, Morita R, Yoshimura A, Takeuchi T.
    Arthritis Res Ther; 2016 May 14; 18(1):106. PubMed ID: 27180164
    [Abstract] [Full Text] [Related]

  • 4. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
    Traianos EY, Locke J, Lendrem D, Bowman S, Hargreaves B, Macrae V, UK primary Sjögren’s syndrome registry, Tarn JR, Ng WF.
    Rheumatol Int; 2020 Apr 14; 40(4):541-548. PubMed ID: 32047959
    [Abstract] [Full Text] [Related]

  • 5. Utility of lymphocyte phenotype profile to differentiate primary Sjögren's syndrome from sicca syndrome.
    Loureiro-Amigo J, Palacio-García C, Martínez-Gallo M, Martínez-Valle F, Ramentol-Sintas M, Soláns-Laqué R.
    Rheumatology (Oxford); 2021 Dec 01; 60(12):5647-5658. PubMed ID: 33620072
    [Abstract] [Full Text] [Related]

  • 6. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
    Chen C, Liang Y, Zhang Z, Zhang Z, Yang Z.
    Int Immunopharmacol; 2020 Nov 01; 88():106878. PubMed ID: 32791244
    [Abstract] [Full Text] [Related]

  • 7. Association between memory B-cells and clinical and immunological features of primary Sjögren's syndrome and Sicca patients.
    Barcelos F, Martins C, Papoila A, Geraldes C, Cardigos J, Nunes G, Lopes T, Alves N, Vaz-Patto J, Branco J, Borrego LM.
    Rheumatol Int; 2018 Jun 01; 38(6):1063-1073. PubMed ID: 29623391
    [Abstract] [Full Text] [Related]

  • 8. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L, Goules AV, Stergiou IE, Voulgarelis M, Tzioufas AG, Kapsogeorgou EK.
    Front Immunol; 2021 Jun 01; 12():705079. PubMed ID: 34484201
    [Abstract] [Full Text] [Related]

  • 9. Association of BAFF and IL-17A with subphenotypes of primary Sjögren's syndrome.
    Deng F, Chen J, Zheng J, Chen Y, Huang R, Yin J, Gao X, Lin Q, Huang C, Gao Y, Yu X, Liu Z.
    Int J Rheum Dis; 2016 Jul 01; 19(7):715-20. PubMed ID: 25941062
    [Abstract] [Full Text] [Related]

  • 10. Elevated CXCL13 in primary Sjögren's syndrome and its correlation with disease activity: a systematic review and meta-analysis.
    Zhu T, Pan Z, Zhang N.
    Clin Rheumatol; 2022 Sep 01; 41(9):2791-2802. PubMed ID: 35616754
    [Abstract] [Full Text] [Related]

  • 11. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
    Liang Y, Xian Z, Fu D, Liu S, Yao Y, Jin Y, Gao C, Shen L, Shi G, He J.
    Front Immunol; 2021 Sep 01; 12():673658. PubMed ID: 34012457
    [Abstract] [Full Text] [Related]

  • 12. Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome.
    Yoshimoto K, Suzuki K, Takei E, Ikeda Y, Takeuchi T.
    Arthritis Res Ther; 2020 Jun 23; 22(1):157. PubMed ID: 32576236
    [Abstract] [Full Text] [Related]

  • 13. Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren's Syndrome.
    Lee SJ, Oh HJ, Choi BY, Jang YJ, Lee JY, Park JK, Song YW.
    J Immunol Res; 2016 Jun 23; 2016():5781070. PubMed ID: 28074193
    [Abstract] [Full Text] [Related]

  • 14. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J, Miceli-Richard C, Gottenberg JE, Ittah M, Lavie F, Lacabaratz C, Gestermann N, Proust A, Lambotte O, Mariette X.
    Ann Rheum Dis; 2007 Jun 23; 66(6):790-7. PubMed ID: 17185325
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication.
    Badarinza M, Serban O, Maghear L, Pelea MA, Rosca RI, Fodor D, Stancu B.
    Med Clin (Barc); 2023 Jun 09; 160(11):484-488. PubMed ID: 37005121
    [Abstract] [Full Text] [Related]

  • 16. Salivary and serum B-cell activating factor (BAFF) levels after hydroxychloroquine treatment in primary Sjögren's syndrome.
    Mumcu G, Biçakçigil M, Yilmaz N, Ozay H, Karaçayli U, Cimilli H, Yavuz S.
    Oral Health Prev Dent; 2013 Jun 09; 11(3):229-34. PubMed ID: 23878841
    [Abstract] [Full Text] [Related]

  • 17. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.
    Gottenberg JE, Seror R, Miceli-Richard C, Benessiano J, Devauchelle-Pensec V, Dieude P, Dubost JJ, Fauchais AL, Goeb V, Hachulla E, Hatron PY, Larroche C, Le Guern V, Morel J, Perdriger A, Puéchal X, Rist S, Saraux A, Sene D, Sibilia J, Vittecoq O, Nocturne G, Ravaud P, Mariette X.
    PLoS One; 2013 Jun 09; 8(5):e59868. PubMed ID: 23717383
    [Abstract] [Full Text] [Related]

  • 18. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome.
    Nossent JC, Lester S, Zahra D, Mackay CR, Rischmueller M.
    Rheumatology (Oxford); 2008 Sep 09; 47(9):1311-6. PubMed ID: 18617551
    [Abstract] [Full Text] [Related]

  • 19. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.
    Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW.
    J Clin Immunol; 2010 Jan 09; 30(1):45-52. PubMed ID: 19774453
    [Abstract] [Full Text] [Related]

  • 20. CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome.
    Nocturne G, Seror R, Fogel O, Belkhir R, Boudaoud S, Saraux A, Larroche C, Le Guern V, Gottenberg JE, Mariette X.
    Arthritis Rheumatol; 2015 Dec 09; 67(12):3226-33. PubMed ID: 26359802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.